ArticleInternal medicine (Tokyo, Japan)2023

Safe Introduction of Hydroxychloroquine Focusing on Early Intolerance Due to Adverse Drug Reactions in Patients with Systemic Lupus Erythematosus.

Yusuke Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.